Histogen Total Assets vs Non Current Assets Total Analysis

HSTO Stock  USD 0.02  0.01  25.65%   
Histogen financial indicator trend analysis is much more than just examining Histogen latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Histogen is a good investment. Please check the relationship between Histogen Total Assets and its Non Current Assets Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.

Total Assets vs Non Current Assets Total

Total Assets vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Histogen Total Assets account and Non Current Assets Total. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Histogen's Total Assets and Non Current Assets Total is -0.49. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Histogen, assuming nothing else is changed. The correlation between historical values of Histogen's Total Assets and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Histogen are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Total Assets i.e., Histogen's Total Assets and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

-0.49
Relationship DirectionNegative 
Relationship StrengthVery Weak

Total Assets

Total assets refers to the total amount of Histogen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Histogen books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from Histogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Histogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.At this time, Histogen's Selling General Administrative is very stable compared to the past year. As of the 23rd of November 2024, Sales General And Administrative To Revenue is likely to grow to 4.44, though Issuance Of Capital Stock is likely to grow to (8.6 K).
 2023 2024 (projected)
Total Revenue19K18.1K
Interest Income653.2K685.9K

Histogen fundamental ratios Correlations

0.10.680.710.66-0.62-0.4-0.190.180.45-0.490.250.980.40.170.78-0.03-0.040.290.41-0.60.98-0.38-0.190.72-0.31
0.10.450.24-0.130.380.18-0.35-0.310.060.540.690.01-0.02-0.35-0.020.250.050.360.280.380.030.370.10.460.48
0.680.450.880.07-0.41-0.36-0.74-0.270.49-0.150.750.620.73-0.130.380.380.30.710.75-0.40.66-0.07-0.080.820.3
0.710.240.880.02-0.37-0.72-0.68-0.210.8-0.150.650.650.67-0.220.240.430.170.640.85-0.370.69-0.03-0.050.910.35
0.66-0.130.070.02-0.390.050.280.44-0.08-0.42-0.230.68-0.240.510.77-0.710.0-0.04-0.4-0.370.67-0.43-0.080.03-0.72
-0.620.38-0.41-0.37-0.390.08-0.04-0.45-0.010.960.19-0.73-0.66-0.41-0.77-0.170.20.05-0.331.0-0.730.640.25-0.320.52
-0.40.18-0.36-0.720.050.080.470.14-0.97-0.02-0.3-0.35-0.250.080.19-0.19-0.18-0.47-0.540.07-0.36-0.130.0-0.59-0.26
-0.19-0.35-0.74-0.680.28-0.040.470.4-0.56-0.25-0.75-0.09-0.520.080.23-0.27-0.63-0.96-0.56-0.04-0.14-0.320.11-0.51-0.56
0.18-0.31-0.27-0.210.44-0.450.140.4-0.2-0.54-0.480.29-0.160.540.42-0.27-0.32-0.28-0.28-0.450.26-0.44-0.09-0.13-0.66
0.450.060.490.8-0.08-0.01-0.97-0.56-0.20.130.490.370.27-0.16-0.170.260.190.570.63-0.010.40.190.030.720.37
-0.490.54-0.15-0.15-0.420.96-0.02-0.25-0.540.130.46-0.63-0.51-0.47-0.74-0.060.30.25-0.140.96-0.610.610.34-0.110.65
0.250.690.750.65-0.230.19-0.3-0.75-0.480.490.460.120.3-0.33-0.140.310.410.720.560.190.170.090.370.640.58
0.980.010.620.650.68-0.73-0.35-0.090.290.37-0.630.120.420.240.85-0.02-0.140.190.38-0.721.0-0.43-0.20.67-0.39
0.4-0.020.730.67-0.24-0.66-0.25-0.52-0.160.27-0.510.30.42-0.10.290.680.090.350.8-0.660.45-0.14-0.340.550.21
0.17-0.35-0.13-0.220.51-0.410.080.080.54-0.16-0.47-0.330.24-0.10.34-0.470.010.07-0.41-0.40.21-0.42-0.19-0.19-0.79
0.78-0.020.380.240.77-0.770.190.230.42-0.17-0.74-0.140.850.290.34-0.17-0.25-0.130.05-0.760.83-0.57-0.230.3-0.63
-0.030.250.380.43-0.71-0.17-0.19-0.27-0.270.26-0.060.31-0.020.68-0.47-0.17-0.280.030.84-0.18-0.010.15-0.150.520.52
-0.040.050.30.170.00.2-0.18-0.63-0.320.190.30.41-0.140.090.01-0.25-0.280.67-0.070.21-0.080.28-0.02-0.110.3
0.290.360.710.64-0.040.05-0.47-0.96-0.280.570.250.720.190.350.07-0.130.030.670.40.060.240.29-0.10.490.41
0.410.280.750.85-0.4-0.33-0.54-0.56-0.280.63-0.140.560.380.8-0.410.050.84-0.070.4-0.340.410.06-0.110.850.51
-0.60.38-0.4-0.37-0.371.00.07-0.04-0.45-0.010.960.19-0.72-0.66-0.4-0.76-0.180.210.06-0.34-0.720.630.26-0.310.52
0.980.030.660.690.67-0.73-0.36-0.140.260.4-0.610.171.00.450.210.83-0.01-0.080.240.41-0.72-0.41-0.20.69-0.35
-0.380.37-0.07-0.03-0.430.64-0.13-0.32-0.440.190.610.09-0.43-0.14-0.42-0.570.150.280.290.060.63-0.41-0.39-0.030.68
-0.190.1-0.08-0.05-0.080.250.00.11-0.090.030.340.37-0.2-0.34-0.19-0.23-0.15-0.02-0.1-0.110.26-0.2-0.39-0.050.13
0.720.460.820.910.03-0.32-0.59-0.51-0.130.72-0.110.640.670.55-0.190.30.52-0.110.490.85-0.310.69-0.03-0.050.27
-0.310.480.30.35-0.720.52-0.26-0.56-0.660.370.650.58-0.390.21-0.79-0.630.520.30.410.510.52-0.350.680.130.27
Click cells to compare fundamentals

Histogen Account Relationship Matchups

Histogen fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.9M15.0M27.2M19.1M17.2M33.0M
Other Current Liab440K2.1M764K424K381.6K362.5K
Total Current Liabilities1.4M2.8M2.3M1.2M1.1M1.1M
Total Stockholder Equity(37.1M)7.9M21.2M14.4M13.0M16.4M
Property Plant And Equipment Net415K4.7M4.8M5.1M5.9M6.2M
Net Debt(1.9M)(1.5M)(13.9M)(7.5M)(8.6M)(9.0M)
Retained Earnings(43.9M)(62.7M)(77.7M)(88.3M)(79.4M)(83.4M)
Accounts Payable808K539K1.4M382K343.8K326.6K
Cash2.1M6.8M18.7M12.1M10.9M12.3M
Non Current Assets Total484K6.6M5.6M5.6M6.5M6.8M
Non Currrent Assets Other69K1.9M805K523K601.5K1.1M
Cash And Short Term Investments2.1M6.8M18.7M12.5M11.3M10.7M
Common Stock Shares Outstanding590.7K450.9K1.9M3.2M2.9M4.5M
Liabilities And Stockholders Equity2.9M15.0M27.2M19.1M17.2M33.0M
Non Current Liabilities Total39.5M5.3M4.7M4.5M5.1M4.9M
Other Current Assets167K1.2M2.4M848K975.2K1.4M
Other Stockholder Equity(32.2M)55.5M98.8M102.7M92.4M87.1M
Total Liab40.9M8.1M7.1M5.7M5.1M4.9M
Property Plant And Equipment Gross221K4.7M4.8M5.1M5.9M6.2M
Total Current Assets2.5M8.4M21.6M13.5M12.1M11.5M
Accumulated Other Comprehensive Income(154.2K)(34K)(39.1M)(15.0M)(13.5M)(12.8M)
Other Assets69K6.3M805K523K601.5K571.4K
Property Plant Equipment415K4.7M4.8M5.1M5.9M6.2M
Current Deferred Revenue14.2M10.1M19K48K17.1K16.2K
Net Receivables110K144K165K99K89.1K84.6K
Other Liab138K118K112K79K71.1K67.5K
Net Tangible Assets(37.1M)7.9M21.2M14.4M16.6M17.4M
Inventory106K300K1.7M400K460K716.7K

Pair Trading with Histogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Histogen Stock

  0.69RNXT RenovoRxPairCorr
  0.51MDGL Madrigal PharmaceuticalsPairCorr
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Histogen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Histogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Histogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Histogen Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.81)
Revenue Per Share
0.004
Return On Assets
(0.54)
Return On Equity
(1.20)
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.